ClinicalTrials.gov term: Depressive Disorder
Depression clinical trials
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-22
What changed in the last 30 days
216 trials changed in the last 30 days: 4 stopped, 97 with notable changes, 115 with minor changes only.
- Notable: RENEW-MDD-3 · Brenipatide · Major Depressive Disorder Recruitment opened
- Notable: IPSILON · Influence of a PSychological Intensive Support Program for Lung Cancer Patients ON Post-operative Outcomes Recruitment opened
- Notable: Peripartum 40 Hz Audiovisual Stimulation on Postpartum Depression in Women Undergoing Elective Cesarean Section: A Randomized Clinical Trial Recruitment opened
- Minor: HEAL-ABC · E-Mindfulness Approaches for Living After Breast Cancer Enrollment closed, study ongoing
- Minor: Celecoxib on Neuroinflammation in MDD Sponsor refiled this as recruiting (was completed)
- Notable: ISO4SAD · ISO Principle-Based Music Intervention for Reducing Stress, Anxiety, and Depression Primary completion pushed from Aug 30, 2026 to Apr 30, 2027
- Notable: ET+ · Trauma Plus Eligibility criteria changed
- Notable: Lay-Delivered Behavioral Activation in Senior Centers Results posted: Nov 19, 2026
- Notable: ProMOOD · Adjunctive Probiotic Therapy in Major Depressive Disorder Start date pushed from Oct 2026 to Dec 2026
- Minor: NBI-1065845-MDD3026 · Osavampator as an Adjunctive Treatment · Major Depressive Disorder (MDD) Trial sites expanded: 35 → 39 locations
- Minor: NBI-1065845-MDD3025 · Osavampator as an Adjunctive Treatment · Major Depressive Disorder (MDD) Trial sites expanded: 39 → 42 locations
- Minor: Osavampator as an Adjunctive Treatment · Major Depressive Disorder (MDD) Trial sites expanded: 18 → 30 locations
- Stopped: X-NOVA2 · Azetukalner Versus Placebo in Major Depressive Disorder Trial terminated
- Stopped: Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD) Withdrawn before enrolling
- Notable: Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans Enrollment reduced: 30 → 10 participants
- Notable: Guided Imagery on Anxiety, Depression, and Fatigue in Patients Receiving Hemodialysis Primary endpoint(s) modified
- Notable: KeDA · Ketamine for Combined Depression and Alcohol Use Disorder Primary and study completion pushed from Jul 1, 2027 to Jul 1, 2028
- Notable: POWER · Lifestyle Interventions to Prevent Cognitive Deficits · Depressive Symptoms: From Mechanisms to Clinical Practice Primary completion pushed from Aug 2026 to Apr 2027
- Notable: QoL in LSSC · Quality of Life and Functional Outcomes in Laryngeal Cancer Patients Primary completion pushed from Jan 2, 2027 to Jul 2, 2027
- Notable: STAY · Strategic Treatment and Assessment for Youth Primary and study completion pushed from Nov 30, 2026 to Nov 30, 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New sponsor entrants, last 90 days sponsors with their first trial in this area
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-11-20 | NCT07950956 A Prospective, Multicenter, Randomized, No-Treatment Controlled, Evaluator-Blinded… | Fiman (Changchun) Pharmaceutical Biotechnology Company Limited new | |
| 2026-11-20 | NCT07950800 From There Towards Now; Intervention for Jewish and Indonesian Post-war Generations | Arkin new | |
| 2026-11-19 | NCT07948603 Comparing Brief, Low-Intensity Self-Improvement Exercises in a Non-Clinical Population | Spark Wave, LLC new | |
| 2026-11-19 | NCT07949500 Esketamine Plus Sirolimus for Adults With Depression Who Have Not Responded to Esketamine | Rodolfo Furlan Damiano new | Phase 2 |
| 2026-11-18 | NCT07946484 Acupuncture for Depression: Sigma-1 Receptor-Related Brain Network Modulation | Shenzhen Hospital of Guangzhou University of Chinese Medicine new | |
| 2026-11-17 | NCT07943936 Anxiety Reduction, Learning Support, Mood, and Self-efficacy Adaptation in Families With… | Hospital Universitario 12 de Octubre new | |
| 2026-11-17 | NCT07941986 Association Between Maternal Intrapartum Pethidine Exposure and Respiratory Depression in… | Egyptian Chinese University new | |
| 2026-11-17 | NCT07942454 The Effects of Prayer on Psychological, Physical, and Spiritual Well-being in Adults With… | Patricia Kaufman new | |
| 2026-11-16 | NCT07938372 Effect of Guided Imagery on Anxiety, Depression, and Fatigue in Patients Receiving… | Adiyaman University new | |
| 2026-11-13 | NCT07935096 Effect of Nature-based Interventions on Mental Health and Markers of Inflammation in… | Instituto Nacional de Salud, Colombia new |
Active trials by phase
| Early Phase 1 | 18 | |
| Phase 1 | 40 | |
| Phase 1/2 | 27 | |
| Phase 2 | 158 | |
| Phase 2/3 | 17 | |
| Phase 3 | 71 | |
| Phase 4 | 80 |
Not charted: 1,827 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Top sponsors by active trials in this area
Massachusetts General Hospital (42) · Stanford University (26) · Medical University of South Carolina (25) · VA Office of Research and Development (23) · Centre for Addiction and Mental Health (20) · Weill Medical College of Cornell University (20) · University of California, Los Angeles (19) · Shanghai Mental Health Center (17) · University of Pittsburgh (15) · Yale University (15)
Get alerts when Depression trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.